Impact of White Matter Changes on Clinical Manifestation of Alzheimer’s Disease: A Quantitative Study

Background and Purpose There have been conflicting results involving the clinical significance of white matter changes in patients with Alzheimer’s disease (AD). We studied the association between the volume of white matter hyperintensities (WMHs) on T2-weighted images and cognitive, neurological, and neuropsychiatric symptoms. Methods The subjects were 76 AD patients who had WMHs but no obvious cerebrovascular diseases. We quantified the volume of WMHs by using fast-fluid–attenuated inversion recovery images and whole brain atrophy by using 3D spoiled gradient-echo images. Effects of WMHs and brain atrophy on dementia severity, cognitive function, neuropsychiatric disturbances, and neurological findings were examined. Results Whole brain atrophy was significantly associated with dementia severity and cognitive disturbances, as well as with grasp reflex and some kinds of neuropsychiatric disturbances. After we controlled for the effects of brain atrophy, duration of symptoms, and demographic factors, we found that WMH volume was not associated with global cognitive disturbances or dementia severity but was significantly associated with urinary incontinence, grasp reflex, and aberrant motor behaviors. Brain atrophy and WMH volume were not significantly correlated either before or after controlling for age, sex, education, and duration of symptoms. WMH volume was associated with hypertension, but brain atrophy was not positively correlated with any vascular risk factors. Conclusions Our results support the hypothesis that WMHs in AD patients are superimposed phenomena of vascular origin. WMHs contribute to specific neurological and neuropsychiatric manifestations but not to global cognitive impairment, which is more closely associated with brain atrophy.

[1]  R. Elble,et al.  Rarefied White Matter in Patients with Alzheimer Disease , 1995, Alzheimer disease and associated disorders.

[2]  R C Grimm,et al.  Initial clinical experience in MR imaging of the brain with a fast fluid-attenuated inversion-recovery pulse sequence. , 1994, Radiology.

[3]  V. Hachinski,et al.  Cognitive and neurologic findings in subjects with diffuse white matter lucencies on computed tomographic scan (leuko-araiosis). , 1987, Archives of neurology.

[4]  P. Scheltens,et al.  White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer’s disease, vascular dementia, and normal aging , 1999, Journal of neurology, neurosurgery, and psychiatry.

[5]  P. Lee,et al.  Smoking and Alzheimer's disease: a review of the epidemiological evidence. , 1994, Neuroepidemiology.

[6]  A. Alavi,et al.  MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. , 1987, AJR. American journal of roentgenology.

[7]  E. Mori,et al.  Premorbid brain size as a determinant of reserve capacity against intellectual decline in Alzheimer's disease. , 1997, The American journal of psychiatry.

[8]  W. Markesbery,et al.  White matter volumes and periventricular white matter hyperintensities in aging and dementia , 2000, Neurology.

[9]  Joseph V. Hajnal,et al.  Use of Fluid Attenuated Inversion Recovery (FLAIR) Pulse Sequences in MRI of the Brain , 1992, Journal of computer assisted tomography.

[10]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[11]  R. Leiguarda,et al.  Neuropsychological, psychiatric, and cerebral perfusion correlates of leukoaraiosis in Alzheimer’s disease , 1997, Journal of neurology, neurosurgery, and psychiatry.

[12]  F. Fazekas,et al.  The relation of cerebral magnetic resonance signal hyperintensities to Alzheimer's disease , 1996, Journal of the Neurological Sciences.

[13]  N. Lassen,et al.  White matter magnetic resonance hyperintensities in dementia of the Alzheimer type: morphological and regional cerebral blood flow correlates. , 1994, Journal of neurology, neurosurgery, and psychiatry.

[14]  R. Schmidt,et al.  Comparison of magnetic resonance imaging in Alzheimer's disease, vascular dementia and normal aging. , 1992, European neurology.

[15]  M. Gado,et al.  Periventricular white matter lucencies in senile dementia of the Alzheimer type and in normal aging , 1987, Neurology.

[16]  B. Ache,et al.  GABA-Mediated Inhibition of Primary Olfactory Receptor Neurons , 1999, Neurosignals.

[17]  P. Colletti,et al.  Quantitative magnetic resonance imaging and the severity of dementia in Alzheimer's disease. , 1988, The American journal of psychiatry.

[18]  J. Wade,et al.  Vascular risk factors and leuko-araiosis. , 1987, Archives of neurology.

[19]  M. Albert,et al.  A standardized technique for establishing onset and duration of symptoms of Alzheimer's disease. , 1995, Archives of neurology.

[20]  R. Schmidt,et al.  Nuclear magnetic resonance image white matter lesions and risk factors for stroke in normal individuals. , 1988, Stroke.

[21]  J. Becker,et al.  Neuropsychiatric correlates of cerebral white-matter radiolucencies in probable Alzheimer's disease. , 1992, Archives of neurology.

[22]  F. Fazekas,et al.  Pathologic correlates of incidental MRI white matter signal hyperintensities , 1993, Neurology.

[23]  L Ketonen,et al.  Do white matter changes on MRI and CT differentiate vascular dementia from Alzheimer's disease? , 1987, Journal of neurology, neurosurgery, and psychiatry.

[24]  O L Lopez,et al.  Computed tomography--but not magnetic resonance imaging--identified periventricular white-matter lesions predict symptomatic cerebrovascular disease in probable Alzheimer's disease. , 1995, Archives of neurology.

[25]  V. Hachinski,et al.  Improved recognition of leukoaraiosis and cognitive impairment in Alzheimer's disease. , 1991, Archives of neurology.

[26]  M. Mascalchi,et al.  Predictors of Leukoaraiosis in Elderly Neurological Patients , 1991 .

[27]  V. Hachinski,et al.  Clinical correlates of white-matter changes on magnetic resonance imaging scans of the brain. , 1991, Archives of neurology.

[28]  P. Colletti,et al.  Magnetic resonance imaging and the severity of dementia in older adults. , 1990, Archives of general psychiatry.

[29]  P. Murali Doraiswamy,et al.  Magnetic resonance findings in patients with early-onset Alzheimer's disease , 1991, Biological Psychiatry.

[30]  L. Harrell,et al.  The relationship of high-intensity signals on magnetic resonance images to cognitive and psychiatric state in Alzheimer's disease. , 1991, Archives of neurology.

[31]  C. P. Hughes,et al.  A New Clinical Scale for the Staging of Dementia , 1982, British Journal of Psychiatry.

[32]  M. Mega,et al.  The Neuropsychiatric Inventory , 1994, Neurology.

[33]  M. Modic,et al.  Magnetic resonance imaging in vascular dementia , 1987, Neurology.

[34]  J. Meyer,et al.  Leukoaraiosis: correlation of MR and CT findings with blood flow, atrophy, and cognition. , 1990, AJNR. American journal of neuroradiology.

[35]  J. Haxby,et al.  The effect of white matter hyperintensity volume on brain structure, cognitive performance, and cerebral metabolism of glucose in 51 healthy adults , 1995, Neurology.

[36]  B Horwitz,et al.  White matter hyperintensities in dementia of Alzheimer's type and in healthy subjects without cerebrovascular risk factors. A magnetic resonance imaging study. , 1990, Archives of neurology.

[37]  W. Markesbery,et al.  Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. , 1997, JAMA.

[38]  M. Nance,et al.  Cognitive consequences of subcortical magnetic resonance imaging changes in Alzheimer's disease: comparison to small vessel ischemic vascular dementia. , 1998, Neuropsychiatry, neuropsychology, and behavioral neurology.

[39]  F. Barkhof,et al.  Histopathologic correlates of white matter changes on MRI in Alzheimer's disease and normal aging , 1995, Neurology.

[40]  K. Ishii,et al.  Changes in cerebral blood flow and oxygen metabolism related to magnetic resonance imaging white matter hyperintensities in Alzheimer's disease. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[41]  O Salonen,et al.  Variable agreement between visual rating scales for white matter hyperintensities on MRI. Comparison of 13 rating scales in a poststroke cohort. , 1997, Stroke.

[42]  D. Inzitari,et al.  Relation between MRI features and dementia in cerebrovascular disease patients with leukoaraiosis: A longitudinal study , 1993, Journal of the Neurological Sciences.

[43]  D. Bennett,et al.  White matter changes: neurobehavioral manifestations of Binswanger's disease and clinical correlates in Alzheimer's disease. , 1994, Dementia.

[44]  D. Leys,et al.  Periventricular and white matter magnetic resonance imaging hyperintensities do not differ between Alzheimer's disease and normal aging. , 1990, Archives of neurology.

[45]  F. Buonanno,et al.  Clinicopathologic correlations of cranial magnetic resonance imaging of periventricular white matter , 1990, Neurology.

[46]  A. Kertesz,et al.  Cognition and white matter changes on magnetic resonance imaging in dementia. , 1990, Archives of neurology.

[47]  P. Scheltens,et al.  White matter lesions on magnetic resonance imaging in clinically diagnosed Alzheimer's disease. Evidence for heterogeneity. , 1992, Brain : a journal of neurology.

[48]  E. Mori,et al.  Effect of the Apolipoprotein E ε4 Allele on White Matter Hyperintensities in Dementia , 2000 .

[49]  L. Caplan.  Binswanger's disease--revisited , 1995, Neurology.

[50]  K. Davis,et al.  The Alzheimer's disease assessment scale: an instrument for assessing treatment efficacy. , 1983, Psychopharmacology bulletin.

[51]  C. Grady,et al.  Comparison of positron emission tomography, cognition, and brain volume in Alzheimer's disease with and without severe abnormalities of white matter. , 1996, Journal of neurology, neurosurgery, and psychiatry.

[52]  Minoru Yasuda,et al.  Apolipoprotein E ε4 Allele and Whole Brain Atrophy in Late-Onset Alzheimer's Disease , 1998 .

[53]  F. W. Brown,et al.  White matter hyperintensity signals in psychiatric and nonpsychiatric subjects. , 1992, The American journal of psychiatry.

[54]  B Horwitz,et al.  Dissociation between corpus callosum atrophy and white matter pathology in Alzheimer's disease , 1998, Neurology.

[55]  M. Husain,et al.  Cerebral white matter disease in late-onset paranoid psychosis , 1990, Biological Psychiatry.

[56]  K. Ishii,et al.  Role of functional brain imaging in the evaluation of vascular dementia. , 1999, Alzheimer disease and associated disorders.

[57]  S. Lin-Chao,et al.  Reduced Inhibition of DNA Synthesis and G(2) Arrest during the Cell Cycle of Resistant HeLa Cells in Response to cis-Diamminedichloroplatinum. , 1994, Journal of biomedical science.

[58]  F. Buonanno,et al.  Comparison of magnetic resonance and roentgen ray computed tomography in dementia. , 1987, Archives of neurology.

[59]  C. Loeb,et al.  Dementia Associated With Lacunar Infarction , 1992, Stroke.

[60]  Heinz Katschnig,et al.  Diagnostic and statistical manual of mental disorders, third edition, revised (DSM-III-R) , 1992 .

[61]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[62]  Yasuo Nishihara,et al.  Why do frontal lobe symptoms predominate in vascular dementia with lacunes? , 1986, Neurology.

[63]  H Lechner,et al.  White matter signal abnormalities in normal individuals: correlation with carotid ultrasonography, cerebral blood flow measurements, and cerebrovascular risk factors. , 1988, Stroke.

[64]  D. Salmon,et al.  Association of dementia severity with cortical gray matter and abnormal white matter volumes in dementia of the Alzheimer type. , 1996, Archives of neurology.

[65]  Donald H. Lee,et al.  Lack of difference in brain hyperintensities between patients with early Alzheimer's disease and control subjects. , 1994, Archives of neurology.

[66]  O Almkvist,et al.  White-matter hyperintensity and neuropsychological functions in dementia and healthy aging. , 1992, Archives of neurology.

[67]  B. Ott,et al.  A SPECT imaging study of MRI white matter hyperintensity in patients with degenerative dementia. , 1997, Dementia and geriatric cognitive disorders.

[68]  G. Román,et al.  Senile dementia of the Binswanger type. A vascular form of dementia in the elderly. , 1987, JAMA.

[69]  C. DeCarli,et al.  Association of midlife blood pressure to late-life cognitive decline and brain morphology , 1998, Neurology.

[70]  Clinical correlates of Alzheimer's disease with and without silent radiographic abnormalities. , 1995, Archives of neurology.

[71]  L. Wahlund,et al.  White matter hyperintensities in dementia: does it matter? , 1994, Magnetic resonance imaging.